Ametek (AME) Reports In-Line Q3 EPS

Ametek (NYSE: AME) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $998.5 million versus the consensus estimate of $1.04 billion.

Third quarter 2014 results exclude $13.7 million, or $0.05 per diluted share, in Zygo integration costs. A comparison of third quarter 2015 results to last year's reported GAAP and adjusted results is included with the financial tables accompanying the release.

For earnings history and earnings-related data on Ametek (AME) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04